South Korean biotechnology company Pharmicell (KRX:005690) secured a contract worth 6.99 billion won from Doosan Electro-Materials (Changshu) to supply electronic material components to China, according to a Wednesday filing with the Korea Exchange.
The deal represents 6.13% of Pharmicell's total sales in 2025. The contract is valid till July 31, the filing said.